Veeva vs. Salesforce Health Cloud: CRM for Life Sciences in 2026

The Veeva-Salesforce breakup is one of the most consequential platform shifts in life sciences technology. After building its entire CRM on the Salesforce platform for over a decade, Veeva is migrating to its own Vault platform by 2030. Meanwhile, Salesforce launched Life Sciences Cloud to recapture the market Veeva dominated. For commercial operations teams choosing between them, the decision has never been more complex.

The Breakup Context

Veeva built a $2.4B business on top of Salesforce's platform, paying Salesforce roughly 15% of CRM revenue as a platform fee. In 2022, Veeva announced it would migrate off Salesforce to its own Vault platform. Salesforce responded by launching Life Sciences Cloud and partnering with IQVIA. This isn't just a vendor switch - it's a platform war with your data in the middle.

The Field Rep's Daily Grind

For a field representative, the CRM isn't just a database. It's their central tool for planning, executing, and reporting daily activities. Veeva built its reputation on a solid mobile experience, particularly on the iPad. Its offline capabilities are strong. A rep can visit a doctor's office in a remote area, log calls, record sample drops, and capture e-signatures without an internet connection. When they reconnect, the data syncs automatically. This workflow is ingrained in the product. It reduces friction for the rep and ensures data capture, even in challenging environments.

Salesforce Health Cloud offers mobile access through its standard Salesforce Mobile App. While functional, it often requires more customization to match Veeva's out-of-the-box life sciences workflows. You might need to configure custom layouts, offline sync rules, and specific field validation for things like sample accountability. My observation is that Salesforce's mobile experience feels more like a general-purpose CRM adapted for pharma. Veeva's feels purpose-built for a rep driving between clinics all day. This difference impacts adoption and data quality directly.

Bridging Commercial and Clinical Data

The line between commercial and clinical operations blurs more each year. Medical Affairs teams, for instance, need access to clinical trial data to answer complex HCP questions. They use this data to educate and support safe product use. Veeva's strategy is to unify these functions on its Vault platform. You'll find Veeva Vault Clinical Suite modules like Vault eTMF and Vault CTMS. These systems are designed to share data with Vault CRM. This means a medical science liaison (MSL) can quickly pull approved clinical study documents, like a specific Phase 3 trial abstract, directly from Vault, ensuring compliance with internal policies and good clinical practice (GCP) guidelines.

On the Salesforce side, connecting commercial CRM to clinical data often involves integrations with third-party systems. Many companies use Medidata Rave for electronic data capture (EDC) or Oracle Clinical for trial management. Salesforce Health Cloud needs connectors or custom APIs to pull relevant clinical trial summaries or investigator details. While possible, this adds complexity and cost. You might need a separate integration layer, like MuleSoft, to manage these data flows. This approach requires more upfront architecture work and ongoing maintenance to keep data synchronized and compliant.

Market Access and Payer Engagement

Market Access teams face unique challenges. They need to understand formulary coverage, manage payer accounts, and track contract performance. Veeva CRM offers specific modules for Market Access. These tools help teams manage payer hierarchies, track formulary status by plan, and plan engagements with health systems. The data model supports complex contract structures and rebate agreements. For instance, you can see how a drug is covered by a specific Medicare Part D plan in Texas, then plan a meeting with that plan's medical director. This built-in functionality helps teams navigate the intricate payer landscape.

Salesforce Health Cloud can be configured for Market Access, but it requires more customization. You would build custom objects for payer organizations, formularies, and contracts. While Salesforce offers powerful platform tools, developing these specific workflows takes significant effort. You might integrate with third-party data providers for formulary data, like MMIT or Fingertip Formulary. The strength of Salesforce is its flexibility. The challenge is that you start with a blank slate for many market access specific processes. This means higher development costs and a longer time to deploy a fully functional system for payer engagement.

Data Model Comparison

Veeva CRM (Vault-based): Purpose-built for life sciences from the ground up. The data model natively understands HCPs, HCOs, therapeutic areas, formularies, samples, and compliance requirements. Territory management, call planning, and medical affairs workflows are first-class objects, not customizations. Veeva Network provides master data management for HCP/HCO data with real-time NPI validation.

Salesforce Health Cloud: Built on the Salesforce platform with industry-specific data models layered on top. The Health Cloud data model covers patients, care plans, and clinical data well but requires significant configuration for commercial pharma use cases. Life Sciences Cloud adds pharma-specific objects, but it's still catching up to Veeva's 12 years of domain refinement.

Compliance and Validation

Veeva: GxP-validated infrastructure with 21 CFR Part 11 compliance built in. Veeva Vault has a proven track record with FDA-regulated processes. Sample management, adverse event reporting, and off-label communication guardrails are native features. For regulated content (like CLM presentations), Veeva PromoMats provides end-to-end compliance.

Salesforce: Shield provides encryption and audit trail capabilities, but GxP validation is the customer's responsibility. Salesforce partners (like Veeva competitor Medidata) offer validated solutions on the platform, but the base platform isn't pre-validated for FDA-regulated workflows. This means higher implementation cost for compliance-heavy use cases.

AI Capabilities

Veeva: CRM Bot (now Vault CRM AI) offers next-best-action suggestions, call planning optimization, and content recommendations. Veeva's AI advantage is training on 15+ years of life sciences-specific interaction data. The models understand pharma sales cycles, formulary dynamics, and HCP engagement patterns.

Salesforce: Einstein GPT and Agentforce bring powerful general-purpose AI with life sciences customization. Salesforce's advantage is the breadth of its AI platform - Einstein can pull insights from marketing, service, and commerce clouds, not just CRM. Data Cloud unifies customer data across touchpoints for more comprehensive HCP profiles.

Total Cost of Ownership

Veeva: Higher per-seat licensing ($150-300/user/month for full CRM Suite) but lower implementation cost because the system works out of the box for life sciences. Migration from Salesforce-based Veeva to Vault-based Veeva is positioned as a "lift and shift" but realistically involves 6-12 months of work per brand team.

Salesforce: Lower base licensing ($75-150/user/month for Health Cloud) but significantly higher implementation and customization cost to match Veeva's out-of-box life sciences functionality. Ongoing customization maintenance adds 20-30% annually. However, if you're already a Salesforce shop across other departments, the platform consolidation savings can be substantial.

The Decision Framework

Choose Veeva Vault CRM if: you're a mid-to-large pharma company with established field teams, need turnkey compliance, and want minimal configuration. The migration from Salesforce-based Veeva is inevitable - better to plan it now.

Choose Salesforce Health Cloud if: you're a biotech or emerging pharma building commercial operations from scratch, already use Salesforce enterprise-wide, or need deep marketing/service integration beyond CRM. The total platform value may outweigh the domain-specific gap.

Choose neither yet if: you're a pre-commercial biotech with fewer than 50 field reps. Consider lighter solutions (Pitcher, Aktana, even HubSpot with compliance add-ons) until your commercial operations justify enterprise CRM investment.